Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the glycomic therapeutics market right now?

The market size for glycomic therapeutics has experienced rapid expansion in the past few years. The market, which was valued at $164.71 billion in 2024, is projected to increase to $190.03 billion in 2025, a compound annual growth rate (CAGR) of 15.4%. The notable growth in the historical period is due to heightened recognition of glycan importance, an upward trend in chronic diseases, the creation of drugs for rare diseases, and partnerships in glycomics research.

How fast Is the glycomic therapeutics market expected to grow, and what’s its future value?

In the coming years, a swift expansion is expected in the glycomic therapeutics market, with projections indicating growth to $361.09 billion in 2029, fuelled by a compound annual growth rate (CAGR) of 17.4%. This projected progression during the forecast period can be credited to factors such as the deepening comprehension of glycan biology, precision-focused medical practices, growing engagement in immunotherapy, amplified funds dedicated to research of rare diseases, and the advent of glycan biomarkers. Key trends for the forecasted timeline encompass the broadening scope of glycomic applications in the field of oncology, glycoengineering strategies for improved therapeutic proteins, utilization of glycomics in immuno-oncology, investigation of glycomics’ role in rare and genetic disorders, and regulatory considerations pertaining to glycomic pharmaceuticals.

Get your glycomic therapeutics market report here!

https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

What are the leading drivers of growth in the glycomic therapeutics market?

The escalation in diabetes occurrences is projected to propel the expansion of the glycomic therapeutics market. Diabetes, a long-term health disorder, hampers the body’s control over blood sugar (glucose) regulation. With Diabetes, changes in glycans are noticed, which may lead to insulin resistance and other metabolic disorders. Specific glycan formations act as biomarkers for the diagnosis of diabetes, foreseeing its development, and tracking the response to treatment. For example, in March 2022, the IDF Diabetes Atlas, headquartered in Belgium, offering extensive data and knowledge on diabetes prevalence globally, anticipates the worldwide increase of diabetes instances from 643 million in 2030 to 783 million in 2045, a surge of 140 million cases. Hence, the growth in diabetes prevalence is stimulating the expansion of the glycomic therapeutics market.

What are the key segments defining the glycomic therapeutics market?

The glycomic therapeutics market covered in this report is segmented –

1) By Class: Isolated, Synthetic

2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures

3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action

4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications

Subsegments:

1) By Isolated: Natural Glycans, Glycan Derivatives, Glycoproteins

2) By Synthetic: Chemically Synthesized Glycans, Recombinant Glycans, Glycopeptides

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp

Who are the key players steering the development of the glycomic therapeutics market?

Major companies operating in the glycomic therapeutics market include F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited

What emerging trends are influencing the growth of the glycomic therapeutics market?

The rise of product innovation is an emerging trend witnessed in the glycomic therapeutics market. Major players in the glycomic therapeutics field are channeling their efforts into creating new and advanced technological solutions to solidify their standing in the industry. An illustration of this is the April 2022 launch of a unique fixed-dose combination (FDC) of a DPP4 inhibitor, Teneligliptin, along with Pioglitazone by Glenmark Pharmaceuticals Limited. The India-based pharmaceutical company developed these innovative therapies to enhance glycemic control and reduce insulin resistance in patients with type 2 diabetes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11894

Which regions are most influential in expanding the glycomic therapeutics market?

North America was the largest region in the glycomic therapeutics in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Acute Myeloid Leukemia Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report

Cancer biologics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

CAR-T Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/car-t-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: